Mt. Sinai Comprehensive Cancer Center

Miami Beach, Florida 33140

1 studies enrolling now · 7 studies all time

What they study most

B-cell Malignancies, Chronic Lymphocytic Leukemia, Malignant Melanoma, Metastatic Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, Platinum Sensitive Ovarian Cancer, Solid Tumor and Hematologic Malignancies

Studies at this site

• A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies — Recruiting now
• XB2001 in Combination With ONIVYDE + 5-FU/LV (+Folinic Acid) in Advanced Pancreatic Cancer — Completed
• Combined AlloStim+Anti-PD-L1 in 4L MSS Metastatic Colorectal Cancer — Withdrawn before enrolling
• Immunotherapy for Third Line Metastatic Colorectal Cancer — Completed
• Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer — Stopped early
• MEK162 for Patients With RAS/RAF/MEK Activated Tumors — Completed
• A Pilot Study of Pivanex in Patients With Malignant Melanoma — Stopped early